Endocrine Abstracts

Introduction: Antithyroidal drug (ATD) therapy is considered as choice of treatment for Graves’ disease; however, the response of treatment varied between patients. Although several studies reported risk factors for relapse after initial treatment, there were few studies for the responsiveness during early treatment period.Method and design: We reviewed 94 patients with Graves’ disease and used their initial TSH receptor antibody (TSHRAb) titre...

Introduction: Anti-thyroidal drug (ATD) therapy is a treatment of choice for Graves’ disease because of its effectiveness and low rate of adverse effect. Response to ATD or remission rate varies among individuals, although there were few useful clues for prediction of treatment response. We applied neural network model to predict response to methimazole, based on clinical symptoms at initial clinical symptoms.Methods & Design: We reviewed 20 new...